BIOCON.NS Profit & Loss
Biocon Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 8 years on file
(FY2018-19 to FY2025-26)
· fetched 2026-08-23 21:39
| Line item | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹5,514.40 Cr. | ₹6,367.20 Cr. | ₹7,105.80 Cr. | ₹8,184.00 Cr. | ₹11,174.20 Cr. | ₹14,755.70 Cr. | ₹15,261.70 Cr. | ₹16,927.00 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | ₹6,029.00 Cr. | ₹6,367.20 Cr. | ₹7,105.80 Cr. | ₹8,184.00 Cr. | ₹11,174.20 Cr. | ₹14,755.70 Cr. | ₹15,261.70 Cr. | ₹16,927.00 Cr. | SegmentRevenueFromOperations |
| Other Income | ₹144.40 Cr. | ₹161.40 Cr. | ₹254.50 Cr. | ₹212.70 Cr. | ₹375.90 Cr. | ₹865.50 Cr. | ₹1,208.20 Cr. | ₹342.50 Cr. | OtherIncome |
| Total Income | ₹5,658.80 Cr. | ₹6,528.60 Cr. | ₹7,360.30 Cr. | ₹8,396.70 Cr. | ₹11,550.10 Cr. | ₹15,621.20 Cr. | ₹16,469.90 Cr. | ₹17,269.50 Cr. | Income |
| Cost of Materials Consumed | ₹1,979.50 Cr. | ₹2,167.60 Cr. | ₹2,430.20 Cr. | ₹2,813.90 Cr. | ₹3,191.10 Cr. | ₹5,071.90 Cr. | ₹4,276.70 Cr. | ₹5,277.60 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹126.80 Cr. | ₹85.40 Cr. | ₹68.40 Cr. | ₹161.10 Cr. | ₹626.10 Cr. | ₹682.70 Cr. | ₹626.60 Cr. | ₹1,362.60 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-209.70 Cr. | ₹-200.80 Cr. | ₹-290.10 Cr. | ₹-256.60 Cr. | ₹-154.10 Cr. | ₹-856.70 Cr. | ₹294.20 Cr. | ₹-949.50 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹1,165.30 Cr. | ₹1,458.80 Cr. | ₹1,741.00 Cr. | ₹1,880.10 Cr. | ₹2,181.00 Cr. | ₹2,664.10 Cr. | ₹3,144.40 Cr. | ₹3,508.00 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹70.90 Cr. | ₹64.90 Cr. | ₹57.70 Cr. | ₹67.60 Cr. | ₹419.00 Cr. | ₹974.40 Cr. | ₹897.40 Cr. | ₹990.30 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹447.80 Cr. | ₹552.20 Cr. | ₹715.10 Cr. | ₹814.20 Cr. | ₹1,113.10 Cr. | ₹1,568.80 Cr. | ₹1,687.00 Cr. | ₹1,956.70 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹1,058.80 Cr. | ₹1,253.10 Cr. | ₹1,503.70 Cr. | ₹1,615.30 Cr. | ₹2,818.40 Cr. | ₹3,895.00 Cr. | ₹3,753.50 Cr. | ₹4,273.00 Cr. | OtherExpenses |
| Total Expenses | ₹4,639.40 Cr. | ₹5,381.20 Cr. | ₹6,226.00 Cr. | ₹7,095.60 Cr. | ₹10,194.60 Cr. | ₹14,000.20 Cr. | ₹14,679.80 Cr. | ₹16,418.70 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹1,019.40 Cr. | ₹1,147.40 Cr. | ₹1,134.30 Cr. | ₹1,301.10 Cr. | ₹1,355.50 Cr. | ₹1,621.00 Cr. | ₹1,790.10 Cr. | ₹850.80 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹194.60 Cr. | ₹67.50 Cr. | ₹12.60 Cr. | ₹-111.10 Cr. | ₹-291.40 Cr. | ₹-11.60 Cr. | ₹96.50 Cr. | ₹-402.90 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹1,214.00 Cr. | ₹1,214.90 Cr. | ₹1,146.90 Cr. | ₹1,190.00 Cr. | ₹1,064.10 Cr. | ₹1,609.40 Cr. | ₹1,886.60 Cr. | ₹447.90 Cr. | ProfitBeforeTax |
| Tax Expense | ₹212.30 Cr. | ₹315.10 Cr. | ₹221.50 Cr. | ₹211.50 Cr. | ₹254.10 Cr. | ₹227.40 Cr. | ₹457.20 Cr. | ₹79.10 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹1,002.60 Cr. | ₹870.90 Cr. | ₹846.20 Cr. | ₹771.60 Cr. | ₹643.00 Cr. | ₹1,297.80 Cr. | ₹1,429.40 Cr. | ₹368.80 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹905.30 Cr. | ₹748.20 Cr. | ₹740.50 Cr. | ₹648.40 Cr. | ₹462.70 Cr. | ₹1,022.50 Cr. | ₹1,013.30 Cr. | ₹385.60 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹15.30 | ₹6.32 | ₹6.24 | ₹5.44 | ₹3.88 | ₹8.55 | ₹8.46 | ₹2.82 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹15.20 | ₹6.30 | ₹6.19 | ₹5.42 | ₹3.87 | ₹8.54 | ₹8.46 | ₹2.82 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from BIOCON.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).